Hardman Johnston Global Advisors LLC purchased a new position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 348,040 shares of the medical instruments supplier’s stock, valued at approximately $20,312,000. Hardman Johnston Global Advisors LLC owned 0.15% of DENTSPLY SIRONA as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also added to or reduced their stakes in the company. Hanseatic Management Services Inc. bought a new position in DENTSPLY SIRONA during the first quarter worth about $30,000. Cornerstone Advisors Inc. increased its position in DENTSPLY SIRONA by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock worth $53,000 after acquiring an additional 346 shares during the period. Arcadia Investment Management Corp MI bought a new position in DENTSPLY SIRONA during the second quarter worth about $58,000. Private Capital Group LLC increased its position in DENTSPLY SIRONA by 74.7% during the first quarter. Private Capital Group LLC now owns 1,223 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 523 shares during the period. Finally, Quadrant Capital Group LLC increased its position in DENTSPLY SIRONA by 1,047.2% during the first quarter. Quadrant Capital Group LLC now owns 1,411 shares of the medical instruments supplier’s stock worth $68,000 after acquiring an additional 1,288 shares during the period. 94.13% of the stock is currently owned by institutional investors and hedge funds.
Shares of XRAY traded down $0.37 during mid-day trading on Tuesday, reaching $53.16. The company had a trading volume of 19,914 shares, compared to its average volume of 1,976,455. The company’s 50 day simple moving average is $55.23 and its 200 day simple moving average is $51.80. DENTSPLY SIRONA Inc has a 1-year low of $33.93 and a 1-year high of $59.40. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. The company has a market capitalization of $11.73 billion, a price-to-earnings ratio of 26.46, a P/E/G ratio of 1.91 and a beta of 0.97.
In other DENTSPLY SIRONA news, CEO Donald M. Jr. Casey bought 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 29th. The shares were acquired at an average cost of $53.68 per share, for a total transaction of $536,800.00. Following the transaction, the chief executive officer now directly owns 105,631 shares in the company, valued at $5,670,272.08. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Maureen J. Macinnis sold 15,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $56.06, for a total transaction of $840,900.00. Following the sale, the senior vice president now owns 25,360 shares in the company, valued at $1,421,681.60. The disclosure for this sale can be found here. Over the last 90 days, insiders bought 22,720 shares of company stock worth $1,223,243. 0.62% of the stock is currently owned by corporate insiders.
A number of equities research analysts have issued reports on XRAY shares. Evercore ISI started coverage on shares of DENTSPLY SIRONA in a research note on Friday, July 26th. They set an “in-line” rating on the stock. Wellington Shields upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research note on Friday, August 2nd. Wolfe Research started coverage on shares of DENTSPLY SIRONA in a research note on Thursday, May 30th. They set a “peer perform” rating on the stock. HC Wainwright reiterated a “neutral” rating and set a $57.00 price objective (up from $55.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, July 9th. Finally, Barrington Research reiterated a “buy” rating and set a $63.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $54.57.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
See Also: Bear Market
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.